You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
興業控股(00132.HK)擬5443.53萬元收購呼研所醫藥科技(廣州)51%股權
格隆匯 03-14 18:34

格隆匯3月14日丨興業控股(00132.HK)公佈,於2025年3月14日,買方(公司的全資附屬公司)、研究院、周榮、賣方及目標公司呼研所醫藥科技(廣州)有限公司訂立股權轉讓協議,據此,其中包括,買方有條件同意向賣方購買銷售股份(佔目標公司股權51%),總代價爲人民幣5443.53萬元,可予調整。

據悉,目標公司爲一間於2009年10月28日在中國成立的有限責任公司,於公佈日期,其註冊及實繳資本分別爲人民幣6600萬元及人民幣6500萬元。目標公司主要從事位於廣州一個呼吸健康產業園的運營及管理業務,定位爲專業化平臺企業,致力於呼吸疾病領域的成果轉化、孵化及產業化。

生物醫藥產業是國家重點支持、具有重大社會意義的重點產業。目標公司是廣州醫科大學國家大學科技園培育單位的建設主體單位,也是國家呼吸系統疾病臨牀醫學研究中心和呼吸疾病全國重點實驗室的產學研基地的主體平臺和運作管理核心。預期收購事項有助集團與研究院等科研機構建立深入的合作關係,提升集團於行業的影響力,推動科研成果在相關業務的產業化與創新應用,及進一步深化集團在醫療科技及康養服務領域的戰略佈局及資源整合能力,支持本集團在大健康產業鏈中的地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account